AUROPHARMA Corporate Action

Aurobindo Pharma Ltd Share Price

AUROPHARMA

NSE

CMP as on 26-May-23 3:59
₹ 615

icon 9.85 | 1.63%

Open
₹ 591
Turnover(lac)
₹ 9,658
Prev. Close
₹ 605.00
Day's Vol (shares)
₹ 1,570,786
Day's Vol (shares)
₹ 591.25         ₹ 618.00

BSE

CMP as on 26-May-23 3:44
₹ 615

icon 9.55 | 1.58%

Open
₹ 600
Turnover(lac)
₹ 249
Prev. Close
₹ 605.00
Day's Vol (shares)
₹ 57,391
Day's Vol (shares)
₹ 596.45         ₹ 617.45

FUTURE

CMP as on 26-May-23 12:00
₹ 618

icon 9.20 | 1.51%

Open
₹ 604
Open Interest(Contracts)
₹ 9,195,000
VWAP
₹ 609.59
Day's Vol (shares)
₹ 3,287,000
Day's Vol (shares)
₹ 600.50     ₹ 619.60

Corporate Action

Action :

From Date:

To Date:

PurposeAGM DateAnnouncement DateBook Closure Start DateBook Closure End Date
AGM02-Aug-202207-Jul-2022--
AGM 02/08/2022 Source : Business Standard Date : 11.07.2022 Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the copies of the Notice published in the newspapers, Business Standard and Nava Telangana on 08.07.2022, intimating the shareholders that the 35th Annual General Meeting of the Company will be held on Tuesday, August 2, 2022 at 3.30 PM (1ST) through Video Conferencing / Other Audio Visual Means. Pursuant to Section 91 of the Companies Act, 2013 and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Register of Members and Share Transfer Books will remain closed from Friday, July 29, 2022 to Tuesday, August 2, 2022 (both days inclusive). (As Per BSE Announcement dated on 08.07.2022) In continuation to our letter dated July 7, 2022, the 35th Annual General Meeting (AGM) of the Company was held on August 2, 2022 and the business mentioned in the AGM Notice dated June 17, 2022 was transacted. In this regard, please find enclosed the following: 1. Summary of proceedings as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure- I. 2. Voting Results as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as Annexure-II. 3. The Report of Scrutinizer on remote e-voting and voting at AGM (by electronic means) as Annexure- III. Aurobindo Pharma Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement dated on 03.08.2022)